BIOEOTCPharmaceutical PreparationsFiscal year ends December 31

Bio Essence Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.42+0.03 (+7.72%)

Close on Oct 19, 2026

Market cap: $21.38M
P/E (TTM): 10.5
Dividend yield: –

Bio Essence Corp balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Cash & Equivalents	–	0.00	0.00	0.01	0.00	0.01	0.02
Cash & Short-Term Investments	–	0.00	0.00	0.01	0.00	0.01	0.02
Receivables	0.02	0.01	0.04	0.01	0.02	0.05	–
Inventory	–	–	0.14	0.18	0.21	0.27	–
Prepaid Expenses & Other	0.00	0.20	0.01	0.01	0.03	0.00	–
Total Current Assets	0.42	0.28	0.30	0.20	0.26	0.33	–
Property, Plant & Equipment	–	–	0.00	0.25	0.18	0.09	–
Gross Property, Plant & Equipment	–	0.06	0.06	0.46	0.34	0.23	–
Accumulated Depreciation	–	-0.06	-0.06	-0.22	-0.16	-0.14	–
Operating Lease Right-of-Use Assets	–	–	1.43	1.05	1.21	1.37	–
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.01	–
Other Long-Term Assets	–	0.00	1.48	–	–	–	–
Total Assets	0.42	0.28	2.76	1.55	1.70	1.85	–
Accounts Payable	0.05	0.02	0.01	0.05	0.06	0.05	–
Accrued Expenses	–	–	0.00	0.01	–	–	–
Current Portion of Leases	1.50	1.07	0.50	0.16	0.16	0.16	–
Current Income Taxes Payable	–	–	0.01	0.01	0.01	0.02	–
Total Current Liabilities	2.44	2.80	2.45	3.56	2.76	1.89	–
Long-Term Leases	–	0.39	0.94	0.95	1.12	1.28	–
Operating Lease Liabilities	1.50	1.50	1.43	1.11	1.28	1.44	–
Other Long-Term Liabilities	–	0.45	0.99	–	–	–	–
Total Liabilities	2.50	3.25	4.42	4.79	4.13	3.63	–
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	–
Additional Paid-In Capital	7.48	7.48	7.48	4.93	4.93	4.93	–
Retained Earnings	-9.55	-10	-9.14	-8.17	-7.36	-6.71	–
Shareholders' Equity	-2.07	-2.97	-1.66	-3.24	-2.43	-1.78	-1.09
Total Equity	-2.07	-2.97	-1.66	-3.24	-2.43	-1.78	-1.09
Total Liabilities & Equity	0.42	0.28	2.76	1.55	1.70	1.85	–
Shares Outstanding(shares)	38	38	38	33	33	33	–
Deposits	–	–	–	0.04	0.04	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 69.7%
Operating margin: 52.9%
Net margin: 52.1%
Return on equity, FY2025: -35.5%

Financial strength

Current ratio: 0.38
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.0%

Valuation

P/E ratio: 10.5
Price to sales: 7.34
Price to book: 9.13
Dividend yield: –